Meyron

Reference summary — not medical advice or a personal risk estimate.

Hydrochlorothiazide

Group 2A — probably carcinogenicMedications & MedicalbehavioralEvidence: limited_in_humans

Summary

A common blood pressure medication associated with increased skin cancer risk.

Detail

Hydrochlorothiazide is Group 2A with limited evidence for non-melanoma skin cancer (squamous and basal cell) and lip cancer. The proposed mechanism involves photosensitisation of the skin. Sun protection is a reasonable precaution for people taking it; questions about whether to continue or switch antihypertensive medication are clinical decisions between a patient and their care team.

Regional relevance

global

global

Documented in these products

Presence in a product category doesn't imply the product causes cancer. Click each to see the source and context.

Sources

Consumer references

Third-party tools some readers use alongside primary evidence. Meyron doesn't endorse them; we link them because you'll otherwise hit them anyway.